WEE1 and cancer: Dysregulation of protein kinases has been reported in multiple cancers, such as breast (Templeton et al., 2014), stomach (Shiroki et al., 2017), pancreas (James et al., 2020), and CRC (Asante et al., 2019), to affect metabolic reprogramming of cancer cells through the manipulation of signaling pathways.